The Toronto oncological MRI agent spinout has been backed by Facit’s Prospects Oncology vehicle, to target applications including the identification and treatment of tumours in the brain.

Nanology Labs, a Canada-based MRI imaging agent spinout of University of Toronto, has secured an undisclosed amount of funding from commercialisation unit Fight Against Cancer Innovation Trust’s (Facit’s) Prospects Oncology Fund. Founded in 2015, Nanology Labs has devised a nanotechnology-powered contrasting agent for MRI scans that exploits the mineral manganese to delineate early-stage tumours in…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.